Treatment of SOD1-G93A mice with drugs selectively inhibiting iNOS delayed disease onset and extended survival in SOD1-G93A mice, further supporting the role of SC-driven inflammation in ALS pathology [212]. This evidence concerns the gene NOS2 and amyotrophic lateral sclerosis.